Quick Answer
AVAI BIO, INC. reported Research And Development Expense of $27.0 thousand for the year ending 2020.
- This data is from AVAI BIO, INC.'s annual report (Form 10-K), filed with the SEC on August 13, 2020.
- XBRL data for this metric is available from 2019 to 2020 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $0.00 | Q4 2018: $0.00 | Q3 2019: $0.00 | Q4 2019: $0.00 | Q3 2025: $23.8 thousand.
- Historical annual values: Fiscal year 2020: $27.0 thousand | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: